Indiana University-Bren and Melvin Simon Cancer Center — Indianapolis, Indiana

Indiana University-Bren and Melvin Simon Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Indiana University-Bren and Melvin Simon Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Recurrent Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma.

Sponsors: Tracon Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University-Bren and Melvin Simon Cancer Center?

Indiana University-Bren and Melvin Simon Cancer Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University-Bren and Melvin Simon Cancer Center conducted?

Indiana University-Bren and Melvin Simon Cancer Center has 1 clinical trials on record. Their work covers Recurrent Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma.

Is Indiana University-Bren and Melvin Simon Cancer Center accredited by Crixeo Health?

Indiana University-Bren and Melvin Simon Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University-Bren and Melvin Simon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.